Treatment of Type 2 Diabetes and Dyslipidemia with the Natural Plant Alkaloid Berberine
Top Cited Papers
Open Access
- 1 July 2008
- journal article
- research article
- Published by The Endocrine Society in Journal of Clinical Endocrinology & Metabolism
- Vol. 93 (7), 2559-2565
- https://doi.org/10.1210/jc.2007-2404
Abstract
Context: Berberine, a natural plant alkaloid, is usually used as an antibiotic drug. The potential glucose-lowering effect of berberine was noted when it was used for diarrhea in diabetic patients. In vitro and in vivo studies have then showed its effects on hyperglycemia and dyslipidemia. Objective: The objective of the study was to evaluate the efficacy and safety of berberine in the treatment of type 2 diabetic patients with dyslipidemia. Design: One hundred sixteen patients with type 2 diabetes and dyslipidemia were randomly allocated to receive berberine (1.0 g daily) and the placebo for 3 months. The primary outcomes were changes in plasma glucose and serum lipid concentrations. Glucose disposal rate (GDR) was measured using a hyperinsulinemic euglycemic clamp to assess insulin sensitivity. Results: In the berberine group, fasting and postload plasma glucose decreased from 7.0 ± 0.8 to 5.6 ± 0.9 and from 12.0 ± 2.7 to 8.9 ± 2.8 mm/liter, HbA1c from 7.5 ± 1.0% to 6.6 ± 0.7%, triglyceride from 2.51 ± 2.04 to 1.61 ± 1.10 mm/liter, total cholesterol from 5.31 ± 0.98 to 4.35 ± 0.96 mm/liter, and low-density lipoprotein-cholesterol from 3.23 ± 0.81 to 2.55 ± 0.77 mm/liter, with all parameters differing from placebo significantly (P < 0.0001, P < 0.0001, P < 0.0001, P = 0.001, P < 0.0001, and P P = 0.037), although no significant change was found between berberine and placebo groups (P = 0.063). Mild to moderate constipation was observed in five participants in the berberine group. Conclusions: Berberine is effective and safe in the treatment of type 2 diabetes and dyslipidemia.Keywords
This publication has 19 references indexed in Scilit:
- Berberine improves glucose metabolism through induction of glycolysisAmerican Journal of Physiology-Endocrinology and Metabolism, 2008
- Berberine stimulates glucose transport through a mechanism distinct from insulinMetabolism, 2007
- Metabolic SyndromeDiabetes Care, 2006
- Berberine, a Natural Plant Product, Activates AMP-Activated Protein Kinase With Beneficial Metabolic Effects in Diabetic and Insulin-Resistant StatesDiabetes, 2006
- Risks for All-Cause Mortality, Cardiovascular Disease, and Diabetes Associated With the Metabolic SyndromeDiabetes Care, 2005
- Insulin Sensitizing and Insulinotropic Action of Berberine from Cortidis RhizomaBiological & Pharmaceutical Bulletin, 2005
- The Antihyperglycaemic Activity of Berberine Arises from a Decrease of Glucose AbsorptionPlanta Medica, 2003
- Effects of berberine on glucose metabolism in vitroMetabolism, 2002
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes.Diabetes Care, 2000